ribavirin has been researched along with Hospital-Acquired Condition in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Husic-Selimovic, A; Jahic, E; Merhemic, Z; Prohic, D; Sofic, A | 1 |
Cao, LL; Chen, DW; Dong, Y; Gan, Y; Han, J; Wang, FC; Wang, FS; Wang, LM; Wang, P; Xu, ZQ; Yan, JG; Zeng, QL; Zhang, HF; Zhang, XX; Zhang, Z; Zhu, SS | 1 |
Amorosa, VK; Kovarik, CL; Lin, J; Lott, JP | 1 |
Berg, KT; Harrison, AR; Lee, MS; McLoon, LK; Nelson, B | 1 |
4 other study(ies) available for ribavirin and Hospital-Acquired Condition
Article | Year |
---|---|
Impact of Different Sources of Infection on Therapy Response in Chronic Hepatitis C.
Topics: Adult; Antiviral Agents; Blood Transfusion; Bosnia and Herzegovina; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Iatrogenic Disease; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Transfusion Reaction; Treatment Outcome | 2018 |
Interferon-α plus ribavirin yields 98 % sustained virologic response in children aged 1-5 years with iatrogenic chronic hepatitis C.
Topics: Adolescent; Antiviral Agents; Biopsy; Child; Child, Preschool; China; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Iatrogenic Disease; Incidence; Infant; Interferon-alpha; Liver; Male; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome | 2015 |
Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Hyperpigmentation; Iatrogenic Disease; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Pegylated interferon alpha-associated optic neuropathy.
Topics: Antiviral Agents; Atrophy; Blindness; Hepatitis C; Humans; Iatrogenic Disease; Interferon alpha-2; Interferon-alpha; Magnetic Resonance Imaging; Male; Middle Aged; Optic Nerve; Optic Neuropathy, Ischemic; Paresthesia; Peripheral Nerves; Peripheral Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Visual Fields | 2010 |